Mesothelioma Treatment: The Promise of 3D Printing Technology

ByHolly Zink
Mesothelioma Treatment: The Promise of 3D Printing Technology

New technologies offer hope for more effective treatments for malignant pleural mesothelioma. One such innovation is the use of 3D printing and optical scanning. These new technologies refine photodynamic therapy, a promising approach for mesothelioma management.

Understanding Photodynamic Therapy

Photodynamic therapy uses the power of light to target and destroy cancer cells. Activating a photosensitizer with light leads to the death of cancerous tissue. This therapy offers a targeted and less invasive option for treating mesothelioma.

Mesothelioma is aggressive, often diagnosed late, and challenging to treat. Traditional approaches like surgery alone have limited success rates. Photodynamic therapy, when combined with surgery, shows promise in improving outcomes. But, accurately delivering the right dose of light to the affected area is crucial for its success.

Advanced 3D printing techniques have helped in this area. They create precise models that mimic the intricate structures of the human body. By printing models of the pleural cavity, where mesothelioma occurs, researchers can better understand its complexities. They can also tailor treatment plans accordingly.

Researchers first digitally reconstructed the lung cavity using 3D printing and optical scanning. These models are then compared to CT scans to ensure accuracy. By representing the anatomy, these models help in planning therapy dosages.

Promising Results

The reconstructed models show exceptional anatomical precision. They help doctors plan precise dosage calculations. These models enhance treatment planning. And they also serve as valuable tools for education and equipment calibration. This research marks a significant step forward in personalized medicine for mesothelioma patients.

3D printing and optical scanning technologies open new improvements for mesothelioma treatment. Machine learning algorithms may lead to more effective and tailored therapies. Real-time monitoring systems can enhance treatment delivery and minimize side effects.

The combination of 3D printing and optical scanning holds great promise in refining photodynamic therapy for mesothelioma. These technologies improve dosage precision and treatment planning. Together, they offer hope for better outcomes and improved quality of life. As research continues, we look forward to seeing how these advancements will transform mesothelioma treatment in the years to come.

Source:

Sourvanos, Dennis, Hongjing Sun, Timothy C. Zhu, Andreea Dimofte, Brook Byrd, Theresa M. Busch, Keith A. Cengel, Rodrigo Neiva, and Joseph P. Fiorellini. “Three-Dimensional Printing of the Human Lung Pleural Cavity Model for PDT Malignant Mesothelioma.” Photodiagnosis and Photodynamic Therapy, February 10, 2024, 104014. https://doi.org/10.1016/j.pdpdt.2024.104014.

Similar Posts

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • | |

    New Detection System for Mesothelioma

    ByAlex Strauss

    A team of biotech scientists in New York have developed an electrochemical process they say can help clinicians detect mesothelioma cells in blood serum. The system works by detecting a protein (HAPLN1) known to be expressed at high levels in the blood serum of people with malignant pleural mesothelioma. Detecting mesothelioma as early as possible is of critical importance because mesothelioma is such a difficult cancer to treat. Associated with asbestos exposure, mesothelioma starts on the membrane around the lungs, heart, or abdomen. It typically grows quickly and does not respond to conventional treatments like chemotherapy or radiotherapy. Biomarkers like the HAPLN1 protein may be value if they can help clinicians distinguish mesothelioma from other conditions with similar symptoms. The scientists…

  • | |

    New Mesothelioma Test Available Later This Year

    ByAlex Strauss

    A mesothelioma test created and validated at Brigham and Women/s Hospital in Boston could be available to the public within the next couple of months. The test, which will be known by the brand name DecisionDx-Mesothelioma, is designed to test patients who are suspected of having mesothelioma for the expression of a variety of genes. By creating a gene profile, the test can give doctors a clearer picture of which patients with mesothelioma symptoms might actually be suffering from the disease. Friendswood, Texas-based Castle Biosciences has announced that it has acquired the intellectual property and technology rights to the test from Brigham and Women’s. Castle Biosciences specializes in molecular diagnostic tests for rare cancers like mesothelioma. Currently, the company has three proprietary…

  • | |

    New Tools Help Pathologists Make Mesothelioma Diagnosis

    ByAlex Strauss

    Pathologists may be able to do a better job of diagnosing mesothelioma in the lab, thanks to a new set of tools released by the International Mesothelioma Interest Group. A rare malignancy, mesothelioma typically carries a poor prognosis. Part of the reason may be the difficulty of making an accurate diagnosis. Even with sophisticated testing capabilities, including immunohistochemical staining and electron microscopy, it can be difficult to distinguish mesothelioma from other types of cancer. Now, pathologists who work with the International Mesothelioma Interest Group have come up with a list of guidelines they hope will help streamline the process in laboratories around the world. Drawing on their own experiences, as well as studies in peer-reviewed publications and text books, the group came…

  • | |

    Ultrasound: A Safer Way to Manage Mesothelioma?

    ByAlex Strauss

    The same technology used by obstetricians to track pregnancies and by cardiologists to find blood clots may also play a valuable role in managing mesothelioma. An Indonesian mesothelioma doctor says ultrasound technology is not only safer than radiation, but also portable, non-invasive and relatively inexpensive to use. In a recent article published in an Indonesian medical journal, Dr. C.M. Rumende of the University of Indonesia Medical School says ultrasonography of the lungs allows clinicians to diagnose some abnormalities common in mesothelioma, including the buildup of lung fluid known as pleural effusion, more rapidly than they could with other imaging modalities. “In addition to pleural effusion,” observes Dr. Rumende, “other lung disorders can be diagnosed by ultrasound such as peripheral lung tumors,…

  • | |

    Mesothelioma or Lung Cancer? Pleural Fluid May Tell

    ByAlex Strauss

    One of the biggest challenges in treating malignant pleural mesothelioma is making a definitive diagnosis. Mesothelioma is a cancer that occurs in the membranous tissue encasing the lungs and other organs. It is almost always caused by exposure to asbestos. Although mesothelioma is not technically a lung cancer, many of its most common symptoms, such as shortness of breath and coughing, are similar to lung cancer and other lung diseases. Like mesothelioma, many of these diseases cause a buildup of fluid around the lungs known as pleural effusion.  But there are subtle differences in the biochemical composition of that fluid from one disease to the next. A team of medical researchers in Japan is testing a new method for detecting and using…